Skip to main content
. 2010 Nov 15;117(9):2596–2603. doi: 10.1182/blood-2010-05-285379

Table 4.

Response to 4 cycles of BEACOPP

Response Institution, N (%) Central review, N (%)
Complete response (CR) 12 (12) 3 (5)
Partial response 1 (PR1) 60 (62) 52 (81)
Partial response 2 (PR2) 24 (25)* 9 (14)
Stable disease (SD) 1 (1) 0 (0)
Progressive disease (PD) 0 (0) 0 (0)
Not evaluable/unknown 1 34
*

Two patients included here only completed cycles 1 and 2 of BEACOPP.